evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
1157	923	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	0	evidence	0	PMID:31495596	PARTIAL		In the Tel Aviv District, the incidence rates ranged from 0.4 to 1.4 cases per 100,000 population per year during 2007-2017.	The incidence of invasive meningococcal disease in the Tel Aviv District falls within the range of 0.1 to 1 cases per 100,000 population per year mentioned in the statement, but it slightly exceeds the maximum value of 1 in some years.	"{""explanation"": ""The incidence of invasive meningococcal disease in the Tel Aviv District falls within the range of 0.1 to 1 cases per 100,000 population per year mentioned in the statement, but it slightly exceeds the maximum value of 1 in some years."", ""reference"": ""PMID:31495596"", ""snippet"": ""In the Tel Aviv District, the incidence rates ranged from 0.4 to 1.4 cases per 100,000 population per year during 2007-2017."", ""supports"": ""PARTIAL""}"
1158	923	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	0	evidence	1	PMID:26453240	PARTIAL		Most countries had a yearly invasive NmB incidence of less than 2 per 100,000 people. Within these relatively low incidence rates (compared with common causes of invasive bacterial diseases), substantial variation was detected between countries, with a notably higher incidence in Australia, Europe, North America, and South America.	The statement is partially supported as the incidence in developed countries is generally low but can exceed the maximum value of 1 case per 100,000 population per year in some regions.	"{""explanation"": ""The statement is partially supported as the incidence in developed countries is generally low but can exceed the maximum value of 1 case per 100,000 population per year in some regions."", ""reference"": ""PMID:26453240"", ""snippet"": ""Most countries had a yearly invasive NmB incidence of less than 2 per 100,000 people. Within these relatively low incidence rates (compared with common causes of invasive bacterial diseases), substantial variation was detected between countries, with a notably higher incidence in Australia, Europe, North America, and South America."", ""supports"": ""PARTIAL""}"
1159	924	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	1	evidence	0	PMID:8333768	PARTIAL		This 10 year retrospective study of all causes of bacterial meningitis for children resident in Nottingham District Health Authority area reports an annual incidence rate per 100,000 children aged 0-16 years of 16.0 (95% confidence interval 14.0 to 18.1).	The incidence rate of bacterial meningitis in the Nottingham District Health Authority area is higher than the stated range of 1 to 10 cases per 100,000 population per year. However, this reference does not specifically address developing countries.	"{""explanation"": ""The incidence rate of bacterial meningitis in the Nottingham District Health Authority area is higher than the stated range of 1 to 10 cases per 100,000 population per year. However, this reference does not specifically address developing countries."", ""reference"": ""PMID:8333768"", ""snippet"": ""This 10 year retrospective study of all causes of bacterial meningitis for children resident in Nottingham District Health Authority area reports an annual incidence rate per 100,000 children aged 0-16 years of 16.0 (95% confidence interval 14.0 to 18.1)."", ""supports"": ""PARTIAL""}"
1160	924	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	1	evidence	1	PMID:18181445	PARTIAL		The Hib meningitis annual incidence in three PICs was 70 to 84 per 100,000 children under five years.	The incidence rate of Hib meningitis in Pacific island countries is significantly higher than the stated range of 1 to 10 cases per 100,000 population per year. This suggests that bacterial meningitis can have a higher incidence in certain developing regions, though it does not provide a comprehensive view across all developing countries.	"{""explanation"": ""The incidence rate of Hib meningitis in Pacific island countries is significantly higher than the stated range of 1 to 10 cases per 100,000 population per year. This suggests that bacterial meningitis can have a higher incidence in certain developing regions, though it does not provide a comprehensive view across all developing countries."", ""reference"": ""PMID:18181445"", ""snippet"": ""The Hib meningitis annual incidence in three PICs was 70 to 84 per 100,000 children under five years."", ""supports"": ""PARTIAL""}"
1161	924	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	1	evidence	2	PMID:31671441	PARTIAL		Average annual incidences for N. meningitidis, S. pneumoniae, and H. influenzae, respectively, were 7.5, 2.5, and 0.3.	The average annual incidences for different bacterial causes of meningitis in the African meningitis belt fall within the stated range of 1 to 10 cases per 100,000 population per year, supporting the statement partially.	"{""explanation"": ""The average annual incidences for different bacterial causes of meningitis in the African meningitis belt fall within the stated range of 1 to 10 cases per 100,000 population per year, supporting the statement partially."", ""reference"": ""PMID:31671441"", ""snippet"": ""Average annual incidences for N. meningitidis, S. pneumoniae, and H. influenzae, respectively, were 7.5, 2.5, and 0.3."", ""supports"": ""PARTIAL""}"
1162	925	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	2	evidence	0	PMID:27345176	NO_EVIDENCE		Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment.	The study focuses on Listeria monocytogenes infections and does not provide specific information on the overall case fatality rate for bacterial meningitis.	"{""explanation"": ""The study focuses on Listeria monocytogenes infections and does not provide specific information on the overall case fatality rate for bacterial meningitis."", ""reference"": ""PMID:27345176"", ""snippet"": ""Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment."", ""supports"": ""NO_EVIDENCE""}"
1163	925	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	2	evidence	1	PMID:24568594	NO_EVIDENCE		INTRODUCTION: Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults.	The study mentions a case fatality rate of 15-20% in adults, which does not directly support the statement that the treated case fatality rate is between 10% and 15%.	"{""explanation"": ""The study mentions a case fatality rate of 15-20% in adults, which does not directly support the statement that the treated case fatality rate is between 10% and 15%."", ""reference"": ""PMID:24568594"", ""snippet"": ""INTRODUCTION: Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults."", ""supports"": ""NO_EVIDENCE""}"
1164	925	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	2	evidence	2	PMID:34343128	NO_EVIDENCE		The crude CFR of neonatal meningitis was 32%.	The study provides a case fatality rate of 32% for neonatal meningitis, which is not within the range specified in the statement.	"{""explanation"": ""The study provides a case fatality rate of 32% for neonatal meningitis, which is not within the range specified in the statement."", ""reference"": ""PMID:34343128"", ""snippet"": ""The crude CFR of neonatal meningitis was 32%."", ""supports"": ""NO_EVIDENCE""}"
1165	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	0	PMID:36190396	NO_EVIDENCE		The observed mortality was 33% (38/114 patients).	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:36190396"", ""snippet"": ""The observed mortality was 33% (38/114 patients)."", ""supports"": ""NO_EVIDENCE""}"
1166	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	1	PMID:24568594	NO_EVIDENCE		Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:24568594"", ""snippet"": ""Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults."", ""supports"": ""NO_EVIDENCE""}"
1167	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	2	PMID:27345176	NO_EVIDENCE		Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:27345176"", ""snippet"": ""Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment."", ""supports"": ""NO_EVIDENCE""}"
1168	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	3	PMID:25442861	NO_EVIDENCE		A total of 175 children with confirmed bacterial meningitis were enrolled.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:25442861"", ""snippet"": ""A total of 175 children with confirmed bacterial meningitis were enrolled."", ""supports"": ""NO_EVIDENCE""}"
1169	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	4	PMID:18254060	NO_EVIDENCE		Acute bacterial meningitis remains a disease with high mortality and morbidity rates.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:18254060"", ""snippet"": ""Acute bacterial meningitis remains a disease with high mortality and morbidity rates."", ""supports"": ""NO_EVIDENCE""}"
1170	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	5	PMID:34343128	NO_EVIDENCE		The crude CFR of neonatal meningitis was 32%.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:34343128"", ""snippet"": ""The crude CFR of neonatal meningitis was 32%."", ""supports"": ""NO_EVIDENCE""}"
1171	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	6	PMID:20485712	NO_EVIDENCE		Meningococcal disease remains a significant illness with an overall mortality of around 8%.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:20485712"", ""snippet"": ""Meningococcal disease remains a significant illness with an overall mortality of around 8%."", ""supports"": ""NO_EVIDENCE""}"
1172	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	7	PMID:20453662	NO_EVIDENCE		BM in cirrhotic patients is associated with a high mortality rate.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:20453662"", ""snippet"": ""BM in cirrhotic patients is associated with a high mortality rate."", ""supports"": ""NO_EVIDENCE""}"
1173	926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	evidence	8	PMID:22029523	NO_EVIDENCE		Despite targeted therapy, case-fatality rates and neurologic sequelae of bacterial meningitis remain unacceptably high.	This study provides data on treated cases of bacterial meningitis, not untreated cases.	"{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:22029523"", ""snippet"": ""Despite targeted therapy, case-fatality rates and neurologic sequelae of bacterial meningitis remain unacceptably high."", ""supports"": ""NO_EVIDENCE""}"
1440	1138	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	epidemiology	0	evidence	0	PMID:1053441	SUPPORT	HUMAN_CLINICAL	Among fifty-three Salt Lake City, Utah area pigeon fanciers, 21% were found to have the clinical picture of pigeon breeders' disease.	The study documents a high prevalence among exposed pigeon fanciers.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study documents a high prevalence among exposed pigeon fanciers."", ""reference"": ""PMID:1053441"", ""snippet"": ""Among fifty-three Salt Lake City, Utah area pigeon fanciers, 21% were found to have the clinical picture of pigeon breeders' disease."", ""supports"": ""SUPPORT""}"
1441	1139	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	epidemiology	1	evidence	0	PMID:21870048	SUPPORT	HUMAN_CLINICAL	Bird fancier's lung (BFL) resulting from avian antigen exposure is a very common form of hypersensitivity pneumonitis.	The review describes BFL as a very common form of HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The review describes BFL as a very common form of HP."", ""reference"": ""PMID:21870048"", ""snippet"": ""Bird fancier's lung (BFL) resulting from avian antigen exposure is a very common form of hypersensitivity pneumonitis."", ""supports"": ""SUPPORT""}"
1604	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	0	PMID:21860658	NO_EVIDENCE		R(0) has been widely used as a measure of disease strength to estimate the effectiveness of control measures and to form the backbone of disease-management policy.	The abstract discusses the use of R0 in understanding disease spread but does not detail specific values or factors affecting R0 for cholera.	"{""explanation"": ""The abstract discusses the use of R0 in understanding disease spread but does not detail specific values or factors affecting R0 for cholera."", ""reference"": ""PMID:21860658"", ""snippet"": ""R(0) has been widely used as a measure of disease strength to estimate the effectiveness of control measures and to form the backbone of disease-management policy."", ""supports"": ""NO_EVIDENCE""}"
1605	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	1	PMID:22937199	NO_EVIDENCE		The two most distinguishing epidemiologic features of the disease are its tendency to appear in explosive outbreaks and its predisposition to causing pandemics.	The abstract provides an overview of cholera's epidemiology but does not mention specific R0 values or the factors affecting R0.	"{""explanation"": ""The abstract provides an overview of cholera's epidemiology but does not mention specific R0 values or the factors affecting R0."", ""reference"": ""PMID:22937199"", ""snippet"": ""The two most distinguishing epidemiologic features of the disease are its tendency to appear in explosive outbreaks and its predisposition to causing pandemics."", ""supports"": ""NO_EVIDENCE""}"
1606	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	2	PMID:36654005	PARTIAL		the basic reproduction number is calculated. When the basic reproduction number is less than one, the disease-free equilibrium is locally stable.	The abstract discusses the calculation of the basic reproduction number (R0) for a cholera model but does not mention specific values or the exact factors listed.	"{""explanation"": ""The abstract discusses the calculation of the basic reproduction number (R0) for a cholera model but does not mention specific values or the exact factors listed."", ""reference"": ""PMID:36654005"", ""snippet"": ""the basic reproduction number is calculated. When the basic reproduction number is less than one, the disease-free equilibrium is locally stable."", ""supports"": ""PARTIAL""}"
1607	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	3	PMID:32663235	PARTIAL		The overall R0 across departments was estimated at 2.1 (95% CI: 0.8, 7.3)	The abstract provides an estimated R0 value for cholera in Peru, mentioning spatial variability and correlation with geographic factors but not detailing all the factors listed in the statement.	"{""explanation"": ""The abstract provides an estimated R0 value for cholera in Peru, mentioning spatial variability and correlation with geographic factors but not detailing all the factors listed in the statement."", ""reference"": ""PMID:32663235"", ""snippet"": ""The overall R0 across departments was estimated at 2.1 (95% CI: 0.8, 7.3)"", ""supports"": ""PARTIAL""}"
1608	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	4	PMID:32678037	NO_EVIDENCE		RESULTS: We estimated the exponential growth rate as 0.22 per day (95% CI: 0.20-0.24), and the basic reproduction number, R0, as 2.37 (95% CI: 2.22-2.51) based on the assumption that the exponential growth starting from 1 March 2020	The abstract discusses the R0 for COVID-19, not cholera.	"{""explanation"": ""The abstract discusses the R0 for COVID-19, not cholera."", ""reference"": ""PMID:32678037"", ""snippet"": ""RESULTS: We estimated the exponential growth rate as 0.22 per day (95% CI: 0.20-0.24), and the basic reproduction number, R0, as 2.37 (95% CI: 2.22-2.51) based on the assumption that the exponential growth starting from 1 March 2020"", ""supports"": ""NO_EVIDENCE""}"
1609	1402	61	Cholera	Cholera.yaml	epidemiology	0	evidence	5	PMID:18091420	NO_EVIDENCE		The incidence of cholera in Bangladesh shows clear seasonality, suggesting that weather factors could play a role in its epidemiology.	The abstract discusses the effect of rainfall on cholera incidence but does not provide specific R0 values or detail the factors affecting R0.	"{""explanation"": ""The abstract discusses the effect of rainfall on cholera incidence but does not provide specific R0 values or detail the factors affecting R0."", ""reference"": ""PMID:18091420"", ""snippet"": ""The incidence of cholera in Bangladesh shows clear seasonality, suggesting that weather factors could play a role in its epidemiology."", ""supports"": ""NO_EVIDENCE""}"
1610	1403	61	Cholera	Cholera.yaml	epidemiology	1	evidence	0	PMID:34550374	NO_EVIDENCE		Cholera outbreaks currently account for 1.3 to 4.0 million cases and cause between 21 000 and 143 000 deaths worldwide. Cholera is preventable by proper sanitization and immunization; however, in many developing nations such as India, cholera disease is endemic.	The provided literature discusses cholera outbreaks and prevention but does not provide specific information on the effective reproduction number (R or Rt) for cholera.	"{""explanation"": ""The provided literature discusses cholera outbreaks and prevention but does not provide specific information on the effective reproduction number (R or Rt) for cholera."", ""reference"": ""PMID:34550374"", ""snippet"": ""Cholera outbreaks currently account for 1.3 to 4.0 million cases and cause between 21 000 and 143 000 deaths worldwide. Cholera is preventable by proper sanitization and immunization; however, in many developing nations such as India, cholera disease is endemic."", ""supports"": ""NO_EVIDENCE""}"
1611	1403	61	Cholera	Cholera.yaml	epidemiology	1	evidence	1	PMID:24245619	NO_EVIDENCE		A new model for the dynamics of cholera is formulated that incorporates both the infection age of infectious individuals and biological age of pathogen in the environment. The basic reproduction number is defined and proved to be a sharp threshold determining whether or not cholera dies out.	While the literature defines the basic reproduction number for cholera, it does not provide specific values for the effective reproduction number (R or Rt) or discuss the factors affecting it.	"{""explanation"": ""While the literature defines the basic reproduction number for cholera, it does not provide specific values for the effective reproduction number (R or Rt) or discuss the factors affecting it."", ""reference"": ""PMID:24245619"", ""snippet"": ""A new model for the dynamics of cholera is formulated that incorporates both the infection age of infectious individuals and biological age of pathogen in the environment. The basic reproduction number is defined and proved to be a sharp threshold determining whether or not cholera dies out."", ""supports"": ""NO_EVIDENCE""}"
1612	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	0	PMID:30594260	NO_EVIDENCE		To evaluate the change in reported cholera cases following Hurricane Matthew on reported cholera cases, we used interrupted time series regression models of daily reported cholera cases, controlling for the impact of both rainfall, following a 4-week lag, and seasonality, from 2013 through 2016.	The reference discusses the change in reported cholera cases following a natural disaster, but does not provide information about the serial interval of cholera.	"{""explanation"": ""The reference discusses the change in reported cholera cases following a natural disaster, but does not provide information about the serial interval of cholera."", ""reference"": ""PMID:30594260"", ""snippet"": ""To evaluate the change in reported cholera cases following Hurricane Matthew on reported cholera cases, we used interrupted time series regression models of daily reported cholera cases, controlling for the impact of both rainfall, following a 4-week lag, and seasonality, from 2013 through 2016."", ""supports"": ""NO_EVIDENCE""}"
1613	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	1	PMID:36654005	NO_EVIDENCE		In this paper, we consider an age-structured cholera model with saturation incidence, vaccination age of vaccinated individuals, infection age of infected individuals, and biological age of pathogens.	Although the reference discusses cholera transmission models, it does not provide data on the serial interval of cholera.	"{""explanation"": ""Although the reference discusses cholera transmission models, it does not provide data on the serial interval of cholera."", ""reference"": ""PMID:36654005"", ""snippet"": ""In this paper, we consider an age-structured cholera model with saturation incidence, vaccination age of vaccinated individuals, infection age of infected individuals, and biological age of pathogens."", ""supports"": ""NO_EVIDENCE""}"
1614	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	2	PMID:32054785	NO_EVIDENCE		We develop a simulation model of the spatial spread of an epidemic in order to examine the impact of a pathogen's incubation period on the dynamics of spread and the predictability of outbreaks.	This reference addresses the impact of incubation periods on the spread and predictability of outbreaks, but does not detail the serial interval for cholera.	"{""explanation"": ""This reference addresses the impact of incubation periods on the spread and predictability of outbreaks, but does not detail the serial interval for cholera."", ""reference"": ""PMID:32054785"", ""snippet"": ""We develop a simulation model of the spatial spread of an epidemic in order to examine the impact of a pathogen's incubation period on the dynamics of spread and the predictability of outbreaks."", ""supports"": ""NO_EVIDENCE""}"
1615	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	3	PMID:30114215	NO_EVIDENCE		We use approximate Bayesian computation to estimate parameters in a climate-driven stochastic epidemic model, including the basic reproduction number R0.	The study provides data on influenza epidemiology, not cholera, and does not mention serial interval.	"{""explanation"": ""The study provides data on influenza epidemiology, not cholera, and does not mention serial interval."", ""reference"": ""PMID:30114215"", ""snippet"": ""We use approximate Bayesian computation to estimate parameters in a climate-driven stochastic epidemic model, including the basic reproduction number R0."", ""supports"": ""NO_EVIDENCE""}"
1616	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	4	PMID:21415490	NO_EVIDENCE		The enormity of human sufferings led clinicians and scientists to carry out extensive research on cholera and Vibrio cholerae (the causative bacterium of the disease), leading to major discoveries.	Although this refers to cholera research, it does not provide specific information about the serial interval of cholera.	"{""explanation"": ""Although this refers to cholera research, it does not provide specific information about the serial interval of cholera."", ""reference"": ""PMID:21415490"", ""snippet"": ""The enormity of human sufferings led clinicians and scientists to carry out extensive research on cholera and Vibrio cholerae (the causative bacterium of the disease), leading to major discoveries."", ""supports"": ""NO_EVIDENCE""}"
1617	1404	61	Cholera	Cholera.yaml	epidemiology	2	evidence	5	PMID:34995131	NO_EVIDENCE		We review methods, applications, challenges and opportunities for real-time infectious disease modeling during public health emergencies, with examples drawn from the two deadliest pandemics in recent history: HIV/AIDS and coronavirus disease 2019 (COVID-19).	This reference discusses real-time disease modeling with a focus on HIV/AIDS and COVID-19, not cholera.	"{""explanation"": ""This reference discusses real-time disease modeling with a focus on HIV/AIDS and COVID-19, not cholera."", ""reference"": ""PMID:34995131"", ""snippet"": ""We review methods, applications, challenges and opportunities for real-time infectious disease modeling during public health emergencies, with examples drawn from the two deadliest pandemics in recent history: HIV/AIDS and coronavirus disease 2019 (COVID-19)."", ""supports"": ""NO_EVIDENCE""}"
1618	1405	61	Cholera	Cholera.yaml	epidemiology	3	evidence	0	PMID:21704640	NO_EVIDENCE		We have quantified a joint distribution of generation time and incubation period by a novel estimation method for household data with two susceptible individuals, consisting of time intervals between disease onsets of two measles cases.	The literature provides information about the generation time and incubation period of measles, not cholera.	"{""explanation"": ""The literature provides information about the generation time and incubation period of measles, not cholera."", ""reference"": ""PMID:21704640"", ""snippet"": ""We have quantified a joint distribution of generation time and incubation period by a novel estimation method for household data with two susceptible individuals, consisting of time intervals between disease onsets of two measles cases."", ""supports"": ""NO_EVIDENCE""}"
1619	1406	61	Cholera	Cholera.yaml	epidemiology	4	evidence	0	PMID:9260522	PARTIAL		The CFR in Africa reached 5.7%, representing the highest figure in all the regions	This shows variability in CFR. Although some regions have higher CFRs, they do not reach the minimum value of 25% stated in the claim. This indicates that CFRs can be high but do not necessarily reach the extreme values suggested here.	"{""explanation"": ""This shows variability in CFR. Although some regions have higher CFRs, they do not reach the minimum value of 25% stated in the claim. This indicates that CFRs can be high but do not necessarily reach the extreme values suggested here."", ""reference"": ""PMID:9260522"", ""snippet"": ""The CFR in Africa reached 5.7%, representing the highest figure in all the regions"", ""supports"": ""PARTIAL""}"
1620	1407	61	Cholera	Cholera.yaml	epidemiology	5	evidence	0	PMID:24101648	PARTIAL		District CFRs ranged from 0% to 14.3%.	The literature indicates a wide range of CFRs, which aligns with the notion that it varies significantly based on access to treatment and quality of care, but it does not provide specific data about the maximum value of 1% in treated cases.	"{""explanation"": ""The literature indicates a wide range of CFRs, which aligns with the notion that it varies significantly based on access to treatment and quality of care, but it does not provide specific data about the maximum value of 1% in treated cases."", ""reference"": ""PMID:24101648"", ""snippet"": ""District CFRs ranged from 0% to 14.3%."", ""supports"": ""PARTIAL""}"
1621	1407	61	Cholera	Cholera.yaml	epidemiology	5	evidence	1	PMID:30184102	PARTIAL		Cholera impacts communities already burdened by conflict, lack of infrastructure, poor health systems, and malnutrition.	This implies variability in CFR based on care access but does not provide explicit maximum CFR values for treated cases.	"{""explanation"": ""This implies variability in CFR based on care access but does not provide explicit maximum CFR values for treated cases."", ""reference"": ""PMID:30184102"", ""snippet"": ""Cholera impacts communities already burdened by conflict, lack of infrastructure, poor health systems, and malnutrition."", ""supports"": ""PARTIAL""}"
1622	1408	61	Cholera	Cholera.yaml	epidemiology	6	evidence	0	PMID:25114012	PARTIAL		The average length of bacterial shedding was 2.0 days (95% confidence interval 1.7-2.4). However, 16 (5%) of 294 contacts shed V. cholerae for >/= 4 days.	The literature indicates an average infectivity period of around 2 days, with some individuals shedding bacteria for 4 or more days, thus partially aligning with the statement's range of 1-10 days.	"{""explanation"": ""The literature indicates an average infectivity period of around 2 days, with some individuals shedding bacteria for 4 or more days, thus partially aligning with the statement's range of 1-10 days."", ""reference"": ""PMID:25114012"", ""snippet"": ""The average length of bacterial shedding was 2.0 days (95% confidence interval 1.7-2.4). However, 16 (5%) of 294 contacts shed V. cholerae for >/= 4 days."", ""supports"": ""PARTIAL""}"
1623	1408	61	Cholera	Cholera.yaml	epidemiology	6	evidence	1	PMID:23201968	PARTIAL		We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6)... 95% by 4.4 days (95% CI 3.9-5.0) after infection.	This estimate focuses on the incubation period rather than the entire infectivity period, providing partial support for the statement’s range of 1-10 days.	"{""explanation"": ""This estimate focuses on the incubation period rather than the entire infectivity period, providing partial support for the statement’s range of 1-10 days."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6)... 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""PARTIAL""}"
1624	1408	61	Cholera	Cholera.yaml	epidemiology	6	evidence	2	PMID:37961651	PARTIAL		Most infections with pandemic Vibrio cholerae are thought to result in subclinical disease and are not captured by surveillance. Previous estimates of the ratio of infections to clinical cases have varied widely (2 to 100).	The infectivity period is implied to have variability, including asymptomatic carriers, but specific durations are not explicitly detailed, offering partial support.	"{""explanation"": ""The infectivity period is implied to have variability, including asymptomatic carriers, but specific durations are not explicitly detailed, offering partial support."", ""reference"": ""PMID:37961651"", ""snippet"": ""Most infections with pandemic Vibrio cholerae are thought to result in subclinical disease and are not captured by surveillance. Previous estimates of the ratio of infections to clinical cases have varied widely (2 to 100)."", ""supports"": ""PARTIAL""}"
1625	1409	61	Cholera	Cholera.yaml	epidemiology	7	evidence	0	PMID:23201968	SUPPORT		We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.	The data indicates that the peak infectivity of cholera post symptom onset occurs between 3 and 5 days.	"{""explanation"": ""The data indicates that the peak infectivity of cholera post symptom onset occurs between 3 and 5 days."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""SUPPORT""}"
1626	1410	61	Cholera	Cholera.yaml	epidemiology	8	evidence	0	PMID:23201968	PARTIAL		We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection.	The statement indicates a mean incubation period range of 2-3 days, whereas the median and the 95th percentile in the literature slightly differ from these ranges. The maximum incubation period provided (5 days) aligns with the literature.	"{""explanation"": ""The statement indicates a mean incubation period range of 2-3 days, whereas the median and the 95th percentile in the literature slightly differ from these ranges. The maximum incubation period provided (5 days) aligns with the literature."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""PARTIAL""}"
1627	1411	61	Cholera	Cholera.yaml	epidemiology	9	evidence	0	PMID:36123095	NO_EVIDENCE		The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000.	The attack rate given in the reference is not directly expressing the percentage range specified in the statement (0.1 to 2 percent).	"{""explanation"": ""The attack rate given in the reference is not directly expressing the percentage range specified in the statement (0.1 to 2 percent)."", ""reference"": ""PMID:36123095"", ""snippet"": ""The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000."", ""supports"": ""NO_EVIDENCE""}"
1628	1412	61	Cholera	Cholera.yaml	epidemiology	10	evidence	0	PMID:35605949	NO_EVIDENCE		The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks.	The literature provides the median attack rate in per 1000 people, not percentages, and does not specify a range of 5%-10%. It mentions attack rates in terms of per thousand people which is not directly related to the percentages specified in the statement.	"{""explanation"": ""The literature provides the median attack rate in per 1000 people, not percentages, and does not specify a range of 5%-10%. It mentions attack rates in terms of per thousand people which is not directly related to the percentages specified in the statement."", ""reference"": ""PMID:35605949"", ""snippet"": ""The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks."", ""supports"": ""NO_EVIDENCE""}"
1629	1412	61	Cholera	Cholera.yaml	epidemiology	10	evidence	1	PMID:37961651	NO_EVIDENCE		Understanding cholera epidemiology and immunity relies on the ability to translate between numbers of clinical cases and the underlying number of infections in the population. We estimated the infection incidence during the first months of an outbreak in a cholera-naive population using a Bayesian vibriocidal antibody titer decay model combining measurements from a representative serosurvey and clinical surveillance data.	This reference discusses the ratio of infections to clinical cases rather than specifying the attack rate range in percentages as stated in the claim.	"{""explanation"": ""This reference discusses the ratio of infections to clinical cases rather than specifying the attack rate range in percentages as stated in the claim."", ""reference"": ""PMID:37961651"", ""snippet"": ""Understanding cholera epidemiology and immunity relies on the ability to translate between numbers of clinical cases and the underlying number of infections in the population. We estimated the infection incidence during the first months of an outbreak in a cholera-naive population using a Bayesian vibriocidal antibody titer decay model combining measurements from a representative serosurvey and clinical surveillance data."", ""supports"": ""NO_EVIDENCE""}"
1630	1413	61	Cholera	Cholera.yaml	epidemiology	11	evidence	0	PMID:18704085	SUPPORT		Here we show that a model incorporating high asymptomatic ratio ... We find that the asymptomatic ratio in cholera is far higher than had been previously supposed.	The study highlights that the asymptomatic ratio in cholera is much higher than previous estimates and provides evidence that it is critical for understanding cholera transmission dynamics.	"{""explanation"": ""The study highlights that the asymptomatic ratio in cholera is much higher than previous estimates and provides evidence that it is critical for understanding cholera transmission dynamics."", ""reference"": ""PMID:18704085"", ""snippet"": ""Here we show that a model incorporating high asymptomatic ratio ... We find that the asymptomatic ratio in cholera is far higher than had been previously supposed."", ""supports"": ""SUPPORT""}"
1631	1413	61	Cholera	Cholera.yaml	epidemiology	11	evidence	1	PMID:32529415	SUPPORT		They indicate the existence of bacteria and asymptomatic individuals in the population of Senegal at any single time.	The study suggests the presence of a significant asymptomatic population that is crucial in the spread and endemicity of cholera.	"{""explanation"": ""The study suggests the presence of a significant asymptomatic population that is crucial in the spread and endemicity of cholera."", ""reference"": ""PMID:32529415"", ""snippet"": ""They indicate the existence of bacteria and asymptomatic individuals in the population of Senegal at any single time."", ""supports"": ""SUPPORT""}"
1632	1413	61	Cholera	Cholera.yaml	epidemiology	11	evidence	2	PMID:2341728	NO_EVIDENCE		A total of 74 inmates (18 symptomatic and 56 asymptomatic) were infected.	Although this study documents asymptomatic cases, it does not provide specific support for the general asymptomatic ratio range (10-80%).	"{""explanation"": ""Although this study documents asymptomatic cases, it does not provide specific support for the general asymptomatic ratio range (10-80%)."", ""reference"": ""PMID:2341728"", ""snippet"": ""A total of 74 inmates (18 symptomatic and 56 asymptomatic) were infected."", ""supports"": ""NO_EVIDENCE""}"
1633	1413	61	Cholera	Cholera.yaml	epidemiology	11	evidence	3	PMID:35259956	PARTIAL		Prognostic metrics of unfolding outbreaks are of particular importance.	This study touches on the role of prognostic indices in understanding outbreaks but does not directly address the asymptomatic ratio range specified (10-80%).	"{""explanation"": ""This study touches on the role of prognostic indices in understanding outbreaks but does not directly address the asymptomatic ratio range specified (10-80%)."", ""reference"": ""PMID:35259956"", ""snippet"": ""Prognostic metrics of unfolding outbreaks are of particular importance."", ""supports"": ""PARTIAL""}"
1795	1520	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	epidemiology	0	evidence	0	PMID:41572562	SUPPORT		Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults.	This abstract explicitly states that CLL is the most common adult leukemia.	"{""explanation"": ""This abstract explicitly states that CLL is the most common adult leukemia."", ""reference"": ""PMID:41572562"", ""snippet"": ""Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults."", ""supports"": ""SUPPORT""}"
2293	2053	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	epidemiology	0	evidence	0	PMID:40753559	SUPPORT		Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL).	This abstract explicitly identifies DLBCL as the most common type of NHL.	"{""explanation"": ""This abstract explicitly identifies DLBCL as the most common type of NHL."", ""reference"": ""PMID:40753559"", ""snippet"": ""Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL)."", ""supports"": ""SUPPORT""}"
2647	2528	111	FICUS syndrome	FICUS_syndrome.yaml	epidemiology	0	evidence	0	PMID:30950647	SUPPORT		The prevalence of psychological outcomes in family caregivers ranged from 4% to 94% for depression, 2% to 80% for anxiety, and 3% to 62% for PTSD.	This provides prevalence ranges across studies for key psychological outcomes in ICU family caregivers.	"{""explanation"": ""This provides prevalence ranges across studies for key psychological outcomes in ICU family caregivers."", ""reference"": ""PMID:30950647"", ""snippet"": ""The prevalence of psychological outcomes in family caregivers ranged from 4% to 94% for depression, 2% to 80% for anxiety, and 3% to 62% for PTSD."", ""supports"": ""SUPPORT""}"
2648	2529	111	FICUS syndrome	FICUS_syndrome.yaml	epidemiology	1	evidence	0	PMID:30950647	SUPPORT		Common risk factors identified for adverse psychological outcomes included younger caregiver age, caregiver relationship to the patient, lower socioeconomic status, and female sex.	This review lists common risk factors associated with psychological outcomes in ICU family caregivers.	"{""explanation"": ""This review lists common risk factors associated with psychological outcomes in ICU family caregivers."", ""reference"": ""PMID:30950647"", ""snippet"": ""Common risk factors identified for adverse psychological outcomes included younger caregiver age, caregiver relationship to the patient, lower socioeconomic status, and female sex."", ""supports"": ""SUPPORT""}"
3135	3119	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	epidemiology	0	evidence	0	PMID:41569770	SUPPORT		Glioblastoma, isocitrate dehydrogenase-wildtype CNS WHO grade 4 (formerly primary glioblastoma multiforme), is the most common and most malignant primary brain tumor.	This abstract explicitly identifies IDH-wildtype glioblastoma as the most common and most malignant primary brain tumor.	"{""explanation"": ""This abstract explicitly identifies IDH-wildtype glioblastoma as the most common and most malignant primary brain tumor."", ""reference"": ""PMID:41569770"", ""snippet"": ""Glioblastoma, isocitrate dehydrogenase-wildtype CNS WHO grade 4 (formerly primary glioblastoma multiforme), is the most common and most malignant primary brain tumor."", ""supports"": ""SUPPORT""}"
3533	3581	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	0	evidence	0	PMID:37322965	PARTIAL		In this regard, we first calculate the basic reproduction number and the equilibrium points of the deterministic Hepatitis B model.	The reference discusses the calculation of the basic reproduction number (R0) for Hepatitis B, which supports the statement about the importance of R0. However, it does not provide specific values for the maximum and minimum R0.	"{""explanation"": ""The reference discusses the calculation of the basic reproduction number (R0) for Hepatitis B, which supports the statement about the importance of R0. However, it does not provide specific values for the maximum and minimum R0."", ""reference"": ""PMID:37322965"", ""snippet"": ""In this regard, we first calculate the basic reproduction number and the equilibrium points of the deterministic Hepatitis B model."", ""supports"": ""PARTIAL""}"
3534	3581	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	0	evidence	1	PMID:16754644	NO_EVIDENCE		Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million have chronic infection, and 600,000 die each year from HBV-related liver disease or hepatocellular carcinoma.	This reference provides epidemiological data on Hepatitis B but does not discuss the basic reproduction number (R0) or its variability.	"{""explanation"": ""This reference provides epidemiological data on Hepatitis B but does not discuss the basic reproduction number (R0) or its variability."", ""reference"": ""PMID:16754644"", ""snippet"": ""Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million have chronic infection, and 600,000 die each year from HBV-related liver disease or hepatocellular carcinoma."", ""supports"": ""NO_EVIDENCE""}"
3535	3581	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	0	evidence	2	PMID:7713188	NO_EVIDENCE		The key determinants of transmission of bloodborne pathogens are the dose and serum viral concentration of an exposure.	This reference focuses on the determinants of transmission of bloodborne pathogens, including Hepatitis B, but does not provide information on the basic reproduction number (R0).	"{""explanation"": ""This reference focuses on the determinants of transmission of bloodborne pathogens, including Hepatitis B, but does not provide information on the basic reproduction number (R0)."", ""reference"": ""PMID:7713188"", ""snippet"": ""The key determinants of transmission of bloodborne pathogens are the dose and serum viral concentration of an exposure."", ""supports"": ""NO_EVIDENCE""}"
3536	3582	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	1	evidence	0	PMID:37322965	PARTIAL		To reduce Hepatitis B infection rates and to promote vaccination rates, three control variables are used, for instance, isolation of patients, treatment of patients, and vaccine inoculation.	The reference discusses control strategies to reduce HBV transmission, which indirectly supports the idea that the effective reproduction number (R or Rt) decreases with effective vaccination and antiviral therapies. However, it does not provide specific values for the effective reproduction number.	"{""explanation"": ""The reference discusses control strategies to reduce HBV transmission, which indirectly supports the idea that the effective reproduction number (R or Rt) decreases with effective vaccination and antiviral therapies. However, it does not provide specific values for the effective reproduction number."", ""reference"": ""PMID:37322965"", ""snippet"": ""To reduce Hepatitis B infection rates and to promote vaccination rates, three control variables are used, for instance, isolation of patients, treatment of patients, and vaccine inoculation."", ""supports"": ""PARTIAL""}"
3537	3583	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	2	evidence	0	PMID:29260504	SUPPORT		a hepatitis B virus (HBV) model with an incubation period and delayed state and control variables is firstly proposed.	The paper discusses a model that includes the incubation period of Hepatitis B, which aligns with the provided statement.	"{""explanation"": ""The paper discusses a model that includes the incubation period of Hepatitis B, which aligns with the provided statement."", ""reference"": ""PMID:29260504"", ""snippet"": ""a hepatitis B virus (HBV) model with an incubation period and delayed state and control variables is firstly proposed."", ""supports"": ""SUPPORT""}"
3538	3584	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	3	evidence	0	PMID:11197043	PARTIAL		Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5-10% of adults and up to 90% of infants will become chronically infected.	The statement is partially supported as it mentions that 5-10% of adults develop chronic hepatitis B infection, which falls within the 2-10% range. However, it also states that up to 90% of infants can become chronically infected, which is not captured in the statement.	"{""explanation"": ""The statement is partially supported as it mentions that 5-10% of adults develop chronic hepatitis B infection, which falls within the 2-10% range. However, it also states that up to 90% of infants can become chronically infected, which is not captured in the statement."", ""reference"": ""PMID:11197043"", ""snippet"": ""Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5-10% of adults and up to 90% of infants will become chronically infected."", ""supports"": ""PARTIAL""}"
3539	3584	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	3	evidence	1	PMID:12616451	PARTIAL		Infants who acquire HBV perinatally have up to 90% risk of developing chronic HBV infection.	The statement is partially supported as it mentions that infants have up to 90% risk of developing chronic HBV infection, but does not provide specific percentages for adults.	"{""explanation"": ""The statement is partially supported as it mentions that infants have up to 90% risk of developing chronic HBV infection, but does not provide specific percentages for adults."", ""reference"": ""PMID:12616451"", ""snippet"": ""Infants who acquire HBV perinatally have up to 90% risk of developing chronic HBV infection."", ""supports"": ""PARTIAL""}"
3540	3584	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	3	evidence	2	PMID:29202763	NO_EVIDENCE		Carrier individuals are especially significant, because they do not exhibit any symptoms and are able to transmit the infection.	This reference discusses the role of carrier individuals in the transmission of hepatitis B but does not provide specific percentages for chronic carriage rates.	"{""explanation"": ""This reference discusses the role of carrier individuals in the transmission of hepatitis B but does not provide specific percentages for chronic carriage rates."", ""reference"": ""PMID:29202763"", ""snippet"": ""Carrier individuals are especially significant, because they do not exhibit any symptoms and are able to transmit the infection."", ""supports"": ""NO_EVIDENCE""}"
3541	3585	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	4	evidence	0	PMID:23185500	PARTIAL		Of 117 participants, 90% of recipients exhibited evidence of exposure to HBV, 42% with HBsAg and/or HBV DNA and 48% anti-HBc reactive without detectable HBV DNA.	The study indicates a high exposure rate to HBV, with a significant proportion of individuals being asymptomatic carriers. However, it does not provide a specific percentage range for asymptomatic individuals.	"{""explanation"": ""The study indicates a high exposure rate to HBV, with a significant proportion of individuals being asymptomatic carriers. However, it does not provide a specific percentage range for asymptomatic individuals."", ""reference"": ""PMID:23185500"", ""snippet"": ""Of 117 participants, 90% of recipients exhibited evidence of exposure to HBV, 42% with HBsAg and/or HBV DNA and 48% anti-HBc reactive without detectable HBV DNA."", ""supports"": ""PARTIAL""}"
3542	3585	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	4	evidence	1	PMID:12616451	PARTIAL		Many HBV-infected children have normal alanine aminotransferase values and minimal chronic hepatitis. Children with chronic HBV infection are usually asymptomatic but may develop chronic liver disease or hepatocellular carcinoma.	The literature mentions that many children with chronic HBV infection are asymptomatic, but it does not specify the exact proportion of asymptomatic cases.	"{""explanation"": ""The literature mentions that many children with chronic HBV infection are asymptomatic, but it does not specify the exact proportion of asymptomatic cases."", ""reference"": ""PMID:12616451"", ""snippet"": ""Many HBV-infected children have normal alanine aminotransferase values and minimal chronic hepatitis. Children with chronic HBV infection are usually asymptomatic but may develop chronic liver disease or hepatocellular carcinoma."", ""supports"": ""PARTIAL""}"
4570	4491	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	0	evidence	0	PMID:37944093	SUPPORT		In the pre-COVID group, we identified 32 of 1,301 patients with LA for an incidence of 0.02 per year... The COVID-onset group consisted of 41 of 641 patients, with an incidence of 0.04 per year.	Washington University single-center data showed incidence doubling during COVID-onset vs pre-COVID periods when dental care was delayed.	"{""explanation"": ""Washington University single-center data showed incidence doubling during COVID-onset vs pre-COVID periods when dental care was delayed."", ""reference"": ""PMID:37944093"", ""snippet"": ""In the pre-COVID group, we identified 32 of 1,301 patients with LA for an incidence of 0.02 per year... The COVID-onset group consisted of 41 of 641 patients, with an incidence of 0.04 per year."", ""supports"": ""SUPPORT""}"
4571	4492	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	1	evidence	0	PMID:34187738	SUPPORT		Mortality ranged from 4% in Benin to 12% in Lagos and it was as high as 19% in Kano.	Multi-center Nigerian series reports mortality spanning 4–19% depending on center.	"{""explanation"": ""Multi-center Nigerian series reports mortality spanning 4–19% depending on center."", ""reference"": ""PMID:34187738"", ""snippet"": ""Mortality ranged from 4% in Benin to 12% in Lagos and it was as high as 19% in Kano."", ""supports"": ""SUPPORT""}"
4572	4493	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	2	evidence	0	PMID:34187738	SUPPORT		Diabetes was the most prevalent underlying systematic condition, affecting 21% of the Ludwig's angina patients in Lagos.	Lagos cohort reports 21% of Ludwig's angina patients had diabetes.	"{""explanation"": ""Lagos cohort reports 21% of Ludwig's angina patients had diabetes."", ""reference"": ""PMID:34187738"", ""snippet"": ""Diabetes was the most prevalent underlying systematic condition, affecting 21% of the Ludwig's angina patients in Lagos."", ""supports"": ""SUPPORT""}"
5121	5022	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	0	evidence	0	PMID:31466978	SUPPORT		he exhibited recurrent facial nerve palsy since the age of 10 years	Documents MRS onset in childhood/adolescence in a clinical case	"{""explanation"": ""Documents MRS onset in childhood/adolescence in a clinical case"", ""reference"": ""PMID:31466978"", ""snippet"": ""he exhibited recurrent facial nerve palsy since the age of 10 years"", ""supports"": ""SUPPORT""}"
5122	5022	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	0	evidence	1	PMID:36532829	SUPPORT		57 children under 18 years of age diagnosed with peripheral facial nerve palsy at Çukurova University... categorized into many groups by etiology... Melkersson-Rosenthal syndrome	Identifies Melkersson-Rosenthal syndrome as a recognized cause of facial palsy in children, establishing pediatric presentation	"{""explanation"": ""Identifies Melkersson-Rosenthal syndrome as a recognized cause of facial palsy in children, establishing pediatric presentation"", ""reference"": ""PMID:36532829"", ""snippet"": ""57 children under 18 years of age diagnosed with peripheral facial nerve palsy at Çukurova University... categorized into many groups by etiology... Melkersson-Rosenthal syndrome"", ""supports"": ""SUPPORT""}"
5123	5022	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	0	evidence	2	PMID:29191347	SUPPORT		Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age... with particular emphasis on age-related differences in the onset, epidemiology, clinical manifestations, prognosis	Establishes that granulomatous diseases including MRS have age-related presentation patterns	"{""explanation"": ""Establishes that granulomatous diseases including MRS have age-related presentation patterns"", ""reference"": ""PMID:29191347"", ""snippet"": ""Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age... with particular emphasis on age-related differences in the onset, epidemiology, clinical manifestations, prognosis"", ""supports"": ""SUPPORT""}"
5124	5023	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	1	evidence	0	PMID:22657098	SUPPORT		Granulomatous cheilitis is a rare disease.	Establishes that MRS/granulomatous cheilitis is a rare disease with low population incidence	"{""explanation"": ""Establishes that MRS/granulomatous cheilitis is a rare disease with low population incidence"", ""reference"": ""PMID:22657098"", ""snippet"": ""Granulomatous cheilitis is a rare disease."", ""supports"": ""SUPPORT""}"
5125	5023	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	1	evidence	1	PMID:29191347	PARTIAL		Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age	Supports that MRS as a granulomatous disease has variable epidemiology depending on population and recognition factors	"{""explanation"": ""Supports that MRS as a granulomatous disease has variable epidemiology depending on population and recognition factors"", ""reference"": ""PMID:29191347"", ""snippet"": ""Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age"", ""supports"": ""PARTIAL""}"
5126	5024	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	2	evidence	0	PMID:31466978	SUPPORT		This case is particularly rare, as the classic triad is seen only in a minority of the cases.	Confirms that the complete triad occurs in only a minority of MRS cases	"{""explanation"": ""Confirms that the complete triad occurs in only a minority of MRS cases"", ""reference"": ""PMID:31466978"", ""snippet"": ""This case is particularly rare, as the classic triad is seen only in a minority of the cases."", ""supports"": ""SUPPORT""}"
5127	5024	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	2	evidence	1	PMID:22657098	SUPPORT		Granulomatous cheilitis (Miescher cheilitis)... is the most common monosymptomatic form of the Melkersson-Rosenthal syndrome.	Demonstrates that monosymptomatic presentations (isolated cheilitis) are common, with only a minority presenting with the complete triad	"{""explanation"": ""Demonstrates that monosymptomatic presentations (isolated cheilitis) are common, with only a minority presenting with the complete triad"", ""reference"": ""PMID:22657098"", ""snippet"": ""Granulomatous cheilitis (Miescher cheilitis)... is the most common monosymptomatic form of the Melkersson-Rosenthal syndrome."", ""supports"": ""SUPPORT""}"
6661	6477	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	0	evidence	0	DOI:10.1038/s41598-021-86029-0	SUPPORT		Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging	This cohort reports a male-predominant sex distribution among imaged individuals.	"{""explanation"": ""This cohort reports a male-predominant sex distribution among imaged individuals."", ""reference"": ""DOI:10.1038/s41598-021-86029-0"", ""snippet"": ""Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"", ""supports"": ""SUPPORT""}"
6662	6478	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	1	evidence	0	PMID:28661492	SUPPORT		There were 64 patients with Proteus syndrome identified in this study, 28 (43.8%) were female and 36 were male (56.3%).	The longitudinal cohort reports a modest male predominance.	"{""explanation"": ""The longitudinal cohort reports a modest male predominance."", ""reference"": ""PMID:28661492"", ""snippet"": ""There were 64 patients with Proteus syndrome identified in this study, 28 (43.8%) were female and 36 were male (56.3%)."", ""supports"": ""SUPPORT""}"
6663	6479	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	2	evidence	0	DOI:10.1038/s41598-021-86029-0	SUPPORT		Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging	The imaging cohort reports an average age of 24 years.	"{""explanation"": ""The imaging cohort reports an average age of 24 years."", ""reference"": ""DOI:10.1038/s41598-021-86029-0"", ""snippet"": ""Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"", ""supports"": ""SUPPORT""}"
6664	6480	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	3	evidence	0	PMID:28661492	SUPPORT		The median age of diagnosis was 19 months.	The cohort analysis reports a median diagnosis age of 19 months.	"{""explanation"": ""The cohort analysis reports a median diagnosis age of 19 months."", ""reference"": ""PMID:28661492"", ""snippet"": ""The median age of diagnosis was 19 months."", ""supports"": ""SUPPORT""}"
7307	7027	303	Sengers syndrome	Sengers_syndrome.yaml	epidemiology	0	evidence	0	DOI:10.1186/s13052-022-01370-y	SUPPORT		Thus far few reported cases have survived the second decade at their latest examination, and no natural history data are available for the disease.	This statement indicates the scarcity of long-term follow-up and limited reported cases.	"{""explanation"": ""This statement indicates the scarcity of long-term follow-up and limited reported cases."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Thus far few reported cases have survived the second decade at their latest examination, and no natural history data are available for the disease."", ""supports"": ""SUPPORT""}"
